Quinolone Resistance–Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time
Authors:
- 1 March 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 47 (3) , 199-201
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Outcomes of Resistance-guided Sequential Treatment ofMycoplasma genitaliumInfections: A Prospective EvaluationClinical Infectious Diseases, 2018
- Use of Pristinamycin for Macrolide-ResistantMycoplasma genitaliumInfectionEmerging Infectious Diseases, 2018
- New Horizons in Mycoplasma genitalium TreatmentThe Journal of Infectious Diseases, 2017
- Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitaliumEmerging Infectious Diseases, 2017
- Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infectionInternational Journal of STD & AIDS, 2017
- Management of Mycoplasma genitalium infections – can we hit a moving target?BMC Infectious Diseases, 2015
- Time to eradication ofMycoplasma genitaliumafter antibiotic treatment in men and womenJournal of Antimicrobial Chemotherapy, 2015
- Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium-Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic RegimensClinical Infectious Diseases, 2014
- A Randomized Comparison of Azithromycin and Doxycycline for the Treatment ofMycoplasma genitalium–Positive Urethritis in MenClinical Infectious Diseases, 2009
- Analysis of the gyrA and parC genes ofMycoplasma genitaliumdetected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatmentJournal of Antimicrobial Chemotherapy, 2001